Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrronium bromide manufacturers

16 products found

Filters

16 products found

glycopyrronium bromide

Inhalation powder 44 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref:Seebri Breezhaler®
Manufacturer #252

Manufacturer usually replies in 2 days

glycopyrronium bromide

Ampoules 200 μg/ml - 1 ml, 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15084

Manufacturer usually replies in 18 days

glycopyrronium bromide

Oral solution 1 mg/5 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10627

Manufacturer usually replies in 9 days

glycopyrronium bromide

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

glycopyrronium bromide

Solution for injection 0.6mg/3ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Unavailable markets
Germany
Manufacturer #11630

Manufacturer usually replies in 4 days

glycopyrronium bromide

Injection 1 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #12311

Manufacturer usually replies in 13 days

glycopyrronium bromide

Solution for injection 0.2 mg, 0.4 mg - 1 ml , 2 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

glycopyrronium bromide

Capsules 63 mcg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #15227
It is a pharmaceutical company founded in 2000 in southeast Europe. The research and production of high-tech inhalers and biotechnology goods is the key focus. The firm specializes in difficult-to-make items and attempts to create high-quality items. It is one of the first companies in a country that started developing biosimilars for international markets, including the United States and the European Union.

Manufacturer usually replies in 2 days

glycopyrronium bromide

Ampoules, injection 200 mcg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Available for
Licensing with supply
Manufacturer #15910

Manufacturer usually replies in 12 days

glycopyrronium bromide

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in nan days

indacaterol + glycopyrronium bromide

Inhalation powder 85 mcg + 43 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Ultibro Breezhaler®
Manufacturer #252

Manufacturer usually replies in 2 days

indacaterol + glycopyrronium bromide

Inhalation powder 85 mcg + 43 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
DPI (Capsule-baser single dose)
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

neostigmine + glycopyrronium bromide

Solution for injection 2.5 mg + 0.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Available for
Licensing with supply
Manufacturer #15910

Manufacturer usually replies in 12 days

indacaterol + glycopyrronium bromide

Capsules 85 mcg + 43 mcg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #15227
It is a pharmaceutical company founded in 2000 in southeast Europe. The research and production of high-tech inhalers and biotechnology goods is the key focus. The firm specializes in difficult-to-make items and attempts to create high-quality items. It is one of the first companies in a country that started developing biosimilars for international markets, including the United States and the European Union.

Manufacturer usually replies in 2 days

indacaterol + glycopyrronium bromide

Inhaler 110 mcg + 50 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

indacaterol + glycopyrronium bromide + mometasone furoate

Inhaler 150 mcg + 50 mcg + 160 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

Glycopyrronium Bromide Manufacturers

Markets of interest

As an antispasmodic Glycopyrronium Bromide prescribed to treat some disorders of the gastrointestinal tract and to reduce salivation with some anesthetics. The substance is available for sale in the form of ampoules, solution for injection, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Glycopyrronium Bromide suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Glycopyrronium Bromide manufacturers and distributors are based in China Bangladesh, and Turkey.

Licensing and brand names

In October 2015, Glycopyrronium Bromide was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD) in the USA. The medication was approved by the EMA in the European Union in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Cuvposa, Enurev Breezhaler. One of the most popular branded versions of Glycopyrronium Bromide is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from India, Spain, Switzerland, Portugal, France, and Italy have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Glycopyrronium Bromide as an active ingredient.

Target supply price

The wholesale acquisition cost for Glycopyrronium Bromide injectable solution (0.2 mg/mL) is around $67 for a supply of 25 milliliters. The retail price of 85mcg + 43 mcg inhalable powder (hard capsules) N30 x 1 + 1 inhaler 46.45 € of the substance in Europe reaches EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Glycopyrronium Bromide manufacturers and suppliers that you are looking for. You can also find the dossier status of Glycopyrronium Bromide and the GMP approvals of the different variants of the medication. The product description of all Glycopyrronium Bromide suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Glycopyrronium Bromide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.